Target intelligence / Profile preview

EGFLAM antisense RNA 2 (EGFLAM-AS2)

Target
EGFLAM-AS2
Molecular classification
Other, Long non-coding RNA (lncRNA), Antisense RNA
01

Overview

EGFLAM antisense RNA 2 (EGFLAM-AS2) is a long non-coding RNA (lncRNA) transcribed from the opposite strand of the EGFLAM gene region. It does not encode a protein and is classified as an antisense RNA[2]. While antisense lncRNAs as a class are known to have important regulatory functions in gene expression, including epigenetic, transcriptional, post-transcriptional, and translational modulation, and can play roles in human disease (particularly cancer), there are currently no studies specifically detailing the function, disease association, druggability, or biomarker status of EGFLAM-AS2 itself[2][3]. As such, it is not considered a canonical therapeutic target, receptor, enzyme, transporter, or other classical drug target at this time. EGFLAM-AS2 may have regulatory roles over the EGFLAM gene or local chromatin structure, but specific biological or clinical relevance remains unreported in the current literature[2][3].

Other names
CTD-2108O9.2EGFLAM antisense RNA 2 (non-protein coding)EGFLAM-AS2
02

Biological functions

Regulation of gene expressionEpigenetic regulationPost-transcriptional regulationOther (Antisense modulation of the EGFLAM locus)
03

Disease associations

Other (Possible involvement in cancer or disease via lncRNA mechanisms, but no direct evidence for EGFLAM-AS2 specifically)

Beyond the preview

Go deeper on EGFLAM antisense RNA 2 (EGFLAM-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EGFLAM antisense RNA 2 (EGFLAM-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call